Literature DB >> 17532010

Roles for VEGF in the adult.

Arindel S R Maharaj1, Patricia A D'Amore.   

Abstract

The role of VEGF during development and in pathology is well known, but its function in normal adult tissues is poorly understood. Adverse effects associated with the use of anti-angiogenic therapies targeting VEGF in human pathologies have begun to reveal potential functions of VEGF in quiescent vasculature. Further clues from expression studies of VEGF and its receptors in the adult, from the disease preeclampsia, and from experimental neutralization studies, have suggested that VEGF is involved in endothelial cell survival and fenestration, as well as in the signaling and maintenance of non-endothelial cells. The various biochemical properties of VEGF, and its interaction with other growth factors, may be an important point in determining whether VEGF functions as a maintenance factor versus an angiogenic factor. A thorough understanding of the function of VEGF in the adult may lead to more efficacious pro- and anti-angiogenic therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17532010      PMCID: PMC2128714          DOI: 10.1016/j.mvr.2007.03.004

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  187 in total

Review 1.  VEGF receptor signalling - in control of vascular function.

Authors:  Anna-Karin Olsson; Anna Dimberg; Johan Kreuger; Lena Claesson-Welsh
Journal:  Nat Rev Mol Cell Biol       Date:  2006-05       Impact factor: 94.444

2.  Sunitinib in patients with metastatic renal cell carcinoma.

Authors:  Robert J Motzer; Brian I Rini; Ronald M Bukowski; Brendan D Curti; Daniel J George; Gary R Hudes; Bruce G Redman; Kim A Margolin; Jaime R Merchan; George Wilding; Michelle S Ginsberg; Jennifer Bacik; Sindy T Kim; Charles M Baum; M Dror Michaelson
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

3.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

Review 4.  The role of growth factors and related agents in accelerating fracture healing.

Authors:  A H R W Simpson; L Mills; B Noble
Journal:  J Bone Joint Surg Br       Date:  2006-06

Review 5.  Signaling from across the way: transactivation of VEGF receptors by HSPGs.

Authors:  Scott B Selleck
Journal:  Mol Cell       Date:  2006-05-19       Impact factor: 17.970

Review 6.  Neovascularization in human atherosclerosis.

Authors:  Pedro R Moreno; K-Raman Purushothaman; Marc Sirol; Andrew P Levy; Valentin Fuster
Journal:  Circulation       Date:  2006-05-09       Impact factor: 29.690

7.  Bevacizumab in metastatic colorectal cancer: a left intracardiac thrombotic event.

Authors:  J Roncalli; J P Delord; M Galinier; P Massabuau; M Lescure; J M Fauvel; D Azria
Journal:  Ann Oncol       Date:  2006-03-08       Impact factor: 32.976

8.  Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Authors:  Ryan M Rich; Philip J Rosenfeld; Carmen A Puliafito; Sander R Dubovy; Janet L Davis; Harry W Flynn; Serafin Gonzalez; William J Feuer; Richard C Lin; Geeta A Lalwani; Jackie K Nguyen; Gaurav Kumar
Journal:  Retina       Date:  2006 May-Jun       Impact factor: 4.256

9.  Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality.

Authors:  Kiichiro Yano; Patricia C Liaw; Janet M Mullington; Shu-Ching Shih; Hitomi Okada; Natalya Bodyak; Peter M Kang; Lisa Toltl; Bryan Belikoff; Jon Buras; Benjamin T Simms; Joseph P Mizgerd; Peter Carmeliet; S Ananth Karumanchi; William C Aird
Journal:  J Exp Med       Date:  2006-05-15       Impact factor: 14.307

Review 10.  Regulation of the ovarian follicular vasculature.

Authors:  Hamish M Fraser
Journal:  Reprod Biol Endocrinol       Date:  2006-04-12       Impact factor: 5.211

View more
  66 in total

1.  L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats.

Authors:  Sydney R Murphy; Babbette LaMarca; Kathy Cockrell; Marietta Arany; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

2.  Corneal epithelial MT1-MMP inhibits vascular endothelial cell proliferation and migration.

Authors:  Dimitri T Azar; Fabio H Casanova; Tatsuya Mimura; Sandeep Jain; Zhongjun Zhou; Kyu Yeon Han; Jin-Hong Chang
Journal:  Cornea       Date:  2010-03       Impact factor: 2.651

3.  Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.

Authors:  Y Totan; T K Akyüz; E Güler; F B Güragaç
Journal:  Eye (Lond)       Date:  2015-11-13       Impact factor: 3.775

4.  Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

Review 5.  A review of anti-VEGF agents for proliferative diabetic retinopathy.

Authors:  P Osaadon; X J Fagan; T Lifshitz; J Levy
Journal:  Eye (Lond)       Date:  2014-02-14       Impact factor: 3.775

Review 6.  Vascular endothelial growth factor control mechanisms in skeletal growth and repair.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  Dev Dyn       Date:  2016-12-29       Impact factor: 3.780

7.  Vascular endothelial growth factor: much more than an angiogenesis factor.

Authors:  Donald R Senger
Journal:  Mol Biol Cell       Date:  2010-02-01       Impact factor: 4.138

8.  Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.

Authors:  Harun Elmasri; Cagatay Karaaslan; Yaroslav Teper; Elisa Ghelfi; Meiqian Weng; Tan A Ince; Harry Kozakewich; Joyce Bischoff; Sule Cataltepe
Journal:  FASEB J       Date:  2009-07-22       Impact factor: 5.191

9.  A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Aleksander S Popel
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

10.  Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions.

Authors:  Stacey D Finley; Aleksander S Popel
Journal:  J Natl Cancer Inst       Date:  2013-05-13       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.